About: Α5IA

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Α5IA Goto Sponge NotDistinct Permalink

An Entity of Type : yago:Whole100003553, within Data Space : dbpedia.org associated with source document(s)
QRcode icon

http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2F%CE%915IA

α5IA (LS-193,268) is a nootropic drug invented in 2004 by a team working for Merck, Sharp and Dohme, which acts as a subtype-selective inverse agonist at the benzodiazepine binding site on the GABAA receptor. It binds to the α1, α2, α3 and α5 subtypes.

Attributes	Values
rdf:type	Thing dul:ChemicalObject chemical substance Drug yago:WikicatMolecularFormulas yago:Abstraction100002137 yago:Adversary109773245 yago:CausalAgent100007347 yago:Communication100033020 yago:Formula106816935 yago:LivingThing100004258 yago:Message106598915 yago:MolecularFormula106817173 yago:Object100002684 yago:Organism100004475 yago:Person100007846 yago:PhysicalEntity100001930 yago:WikicatGABAAntagonists yago:YagoLegalActor yago:YagoLegalActorGeo drug yago:Statement106722453 yago:Whole100003553
rdfs:label	Α5IA (en)
rdfs:comment	α5IA (LS-193,268) is a nootropic drug invented in 2004 by a team working for Merck, Sharp and Dohme, which acts as a subtype-selective inverse agonist at the benzodiazepine binding site on the GABAA receptor. It binds to the α1, α2, α3 and α5 subtypes. (en)
foaf:name	α5IA (en)
foaf:depiction
dcterms:subject	GABAA receptor negative allosteric modulators Triazoles Aromatic ethers Isoxazoles Phthalazines
Wikipage page ID	19165927 (xsd:integer)
Wikipage revision ID	1064902559 (xsd:integer)
Link from a Wikipage to another Wikipage	Benzodiazepine GABAA receptor negative allosteric modulators Triazoles GABRA3 Aromatic ethers GABAA receptor GABAA receptor negative allosteric modulator GABRA2 GABRA5 Local field potential Nootropic Receptor (biochemistry) Inverse agonist Isoxazoles Phthalazines Merck & Co. Sharp waves and ripples GABRA1
sameAs	Α5IA Α5IA Α5IA Α5IA Α5IA
dbp:wikiPageUsesTemplate	dbt:Drugbox dbt:GABA_receptor_modulators dbt:Reflist dbt:Short_description dbt:Fdacite dbt:Lowercase
thumbnail	wiki-commons:Special:FilePath/Alpha5IA.svg?width=300
ATC prefix	None (en)
c	17 (xsd:integer)
CAS number	215874 (xsd:integer)
ChemSpiderID	5293648 (xsd:integer)
drug name	α5IA (en)
H	14 (xsd:integer)
IUPAC name	3 (xsd:integer)
n	8 (xsd:integer)
O	2 (xsd:integer)
PubChem	6918451 (xsd:integer)
SMILES	CC1=CCC2=NN=C3N2N=COCC5=CNC (en)
StdInChI	1 (xsd:integer)
StdInChIKey	NZMJFRXKGUCYNP-UHFFFAOYSA-N (en)
synonyms	LS-193,268 (en)
UNII	1 (xsd:integer)
has abstract	α5IA (LS-193,268) is a nootropic drug invented in 2004 by a team working for Merck, Sharp and Dohme, which acts as a subtype-selective inverse agonist at the benzodiazepine binding site on the GABAA receptor. It binds to the α1, α2, α3 and α5 subtypes. (en)
gold:hypernym	Drug
prov:wasDerivedFrom	wikipedia-en:Α5IA?oldid=1064902559&ns=0
page length (characters) of wiki page	4408 (xsd:nonNegativeInteger)
CAS number	215874-86-5
FDA UNII code	1M7NI1A92L
PubChem	6918451
foaf:isPrimaryTopicOf	wikipedia-en:Α5IA
is Link from a Wikipage to another Wikipage of	C17H14N8O2 GABAA receptor GABAA receptor negative allosteric modulator GABRA5 L-655,708 L-838,417 LS-193,268
is Wikipage redirect of	C17H14N8O2 LS-193,268
is foaf:primaryTopic of	wikipedia-en:Α5IA

Faceted Search & Find service v1.17_git139 as of Feb 29 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 62 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software